| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |